Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients

NCT01262196 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

348

Enrollment

INDUSTRY

Sponsor class

Conditions

Shock, Hemorrhagic
Shock, Traumatic
Acidosis, Lactic

Interventions

DRUG: MP4OX
DRUG: Saline

Sponsor

Sangart